Description: Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovering, developing, and commercializing novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. Disc Medicine, Inc. is based in Watertown, Massachusetts.
Home Page: www.discmedicine.com
IRON Technical Analysis
321 Arsenal Street
Watertown,
MA
02472
United States
Phone:
617 674 9274
Officers
| Name | Title |
|---|---|
| Dr. Donald William Nicholson Ph.D. | Executive Chairman |
| Dr. John D. Quisel Esq., J.D., Ph.D. | CEO, President & Director |
| Dr. William Jacob Savage M.D., Ph.D. | Chief Medical Officer |
| Dr. Brian MacDonald ChB, MB, Ph.D. | Founder & Chair of Scientific Advisory Board |
| Ms. Jean M. Franchi CPA | Chief Financial Officer |
| Mr. Jonathan Yu M.B.A. | Chief Opearating Officer |
| Dr. Rahul Rajan Kaushik Ph.D. | Chief Technical Officer |
| Dr. Rahul Khara J.D., Pharm.D. | General Counsel, Compliance Officer & Secretary |
| Mr. Srikanth Venkatraman Ph.D. | Senior VP & Head of Chemistry |
| Ms. Hua Yang Ph.D. | Senior Vice President & Head of Early Development and Clinical Pharmacology |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.087 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-08-12 |
| Fiscal Year End: | December |
| Full Time Employees: | 82 |